疫情如何影响住院细菌感染儿童的资源利用?
Christina M McKinney1,2,3, Michelle L Mitchell4, Erin Preloger1
1Section of Pediatric Hospital Medicine, Department of Pediatrics, Medical College of Wisconsin, Milwaukee, WI, USA.
Clinical pediatrics
|February 24, 2025
概括
在COVID-19大流行期间,住院儿童接受了更多的实验室检查和心电图 (ECG) 测试. 虽然实验室使用恢复正常,但在高峰后,心电图利用率的增加仍然存在.
科学领域:
- 儿科 儿科 儿科
- 传染性疾病 传染性疾病
- 医疗保健服务研究 医疗服务研究
背景情况:
- COVID-19大流行严重影响了医疗保健和资源利用.
- 了解疫情期间诊断测试和临床管理的变化对于儿科医院医学至关重要.
研究的目的:
- 为了比较实验室测试订单和住院儿童的成像利用在COVID-19大流行之前,期间和之后的峰值.
- 评估心电图 (ECG),心声图,X射线,磁共振成像 (MRI),停留时间 (LOS) 和抗生素时间的变化.
主要方法:
- 儿科患者 (≥60天至<22岁) 患有细胞炎,肺炎或尿路感染的回顾性队列研究.
- 数据收集自2018年3月至2023年4月,分为流行前,流行高峰和流行后阶段.
- 统计分析包括分类变量的费舍尔-弗里曼-哈尔顿精确测试和连续变量的克鲁斯卡尔-瓦利斯测试.
主要成果:
- 在疫情高峰期间入院的患者进行了显著更多的实验室检测和心电图.
- 在疫情高峰期间,使用的MRI和X射线较少.
- 在回声心电图,LOS或阶段之间的抗生素时间之间没有发现显著差异.
- 实验室利用率恢复到大流行前的水平,但在高峰后,心电图的使用量继续增加.
结论:
- 由于COVID-19的流行,医院住院儿童的实验室测试和心电图的使用增加了,特别是在高峰期.
- 在高峰期增加实验室和心电图的使用可能反映出某些细菌感染的诊断不确定性增加.
- 虽然实验室测试订单正常化,但持续增加的心电图利用率需要进一步调查.
更多相关视频
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
15.0K
06:18Quantifying the Effects of Antimicrobials on In vitro Biofilm Architecture using COMSTAT Software
Published on: December 14, 2020
3.2K
相关概念视频
01:22Healthcare Associated Infections II: Preventive Measures
2.4K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
2.4K
01:28Pneumonia IV: Management
286
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
286
00:57Antibiotic Selection
52.2K
Overview
52.2K
01:30Pneumonia III: Complications and Assessment
143
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
143